Satsuma Pharmaceuticals, Inc. Annual Depreciation in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2022.
  • Satsuma Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. Depreciation for the twelve months ending March 31, 2023 was $418K, a 3.21% increase year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2022 was $510K, a 29.8% increase from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2021 was $393K, a 64.4% increase from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Depreciation for 2020 was $239K, a 69.5% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $510K +$117K +29.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $393K +$154K +64.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $239K +$98K +69.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $141K +$84K +147% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $57K +$47K +470% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $10K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.